Tracking and tracing pharmaceuticals

Belleville, Laureen J.
June 2009
Industrial Laser Solutions;Jun2009, Vol. 24 Issue 6, p15
The article highlights the company FP Developments which manufactures production lines for the pharmaceutical and healthcare industries in the U.S. It says that the company has integrated fiber laser coders that are marking data matrix codes, lot codes, or fill numbers on the aluminum bands that go around the top of the vials. In order to enable its customers to comply with federal drug standards, it notes that company designs and manufactures its own laser and verification systems.


Related Articles

  • ENTRY FORMAT.  // Monthly Prescribing Reference;Jun2012, Vol. 28 Issue 6, pA-27 

    The article presents information on key elements available in every pharmaceutical product monograph in the U.S.. It mentions that a brand name is provided under which the product and other dosage forms in the monograph are marketed. It informs that the pharmacology of the drug is also listed in...

  • Elemental Impurity Requirements. Schoneker, David R. // Contract Pharma;Mar2013, Vol. 15 Issue 2, p43 

    A letter to the editor is presented in response to the article "Elemental Impurities Control - USP's New Standards to be required by May 2014" by Dr. Anthony DeStefano and Dr. Kahkashan Zaidi in the October 2012 issue.

  • Will medications be safer in the future? Erickson, Amy K. // Pharmacy Today;Nov2010, Vol. 16 Issue 11, p40 

    The article focuses on issues faced by the U.S. Food and Drug Administration (FDA) concerning safety and quality of drugs manufactured abroad. It highlights on the regulatory system implemented by FDA to ensure that products made outside the U.S. meet the standards of the pharmaceutical...

  • FDA Realigns Drug Inspection and Manufacturing Oversight. Wechsler, Jill // Pharmaceutical Technology Europe;Dec2014, Vol. 26 Issue 12, p20 

    The article offers information on the changes made by the U.S. Food and Drug Administration (FDA) commissioner Margaret Hamburg in operations to improve global market monitoring and the Centre for Drug Evaluation and Research (CDER) reorganisation to support for policies ensuring drug quality....

  • USP's Response: USP in a Global Era. Williams, Roger L. // Pharmaceutical Technology;Sep2011, Vol. 35 Issue 9, p93 

    In this article the author discusses the issue concerning the globalization of United States Pharmacopeia (USP). He notes that the organization's investments have been focused on the advancement of its laboratories in Maryland, India, China, and Brazil that are all supporting USP's...

  • The incredible thinking industry. Chase, James // Medical Marketing & Media;May2011, Vol. 46 Issue 5, p6 

    An introduction to the journal is presented wherein the author discusses the topics to be addressed at the Virtual Summit on May 24, 2011 which focus on the pharmaceutical industry in the U.S.

  • REPORTERS Notebook.  // Drug Store News;2/7/2011, Vol. 33 Issue 2, p28 

    The article offers news briefs related to the pharmaceutical industry in the U.S. including the approval of Watson Pharmaceuticals Inc.'s generic drug by the Food and Drug Administration (FDA), the development of biosimilars by Merck & Co. Inc. and the launch of MyEpiPenn, a smart phone...

  • Clinical Briefs. Kuritzky, Louis // Internal Medicine Alert;1/29/2010, Vol. 32 Issue 2, p16 

    The article offers news briefs related to pharmaceutical industry in the U.S. in 2010.

  • MED ED REPORT: Update.  // Medical Marketing & Media;Apr2011, Vol. 46 Issue 4, p19 

    The article offers news briefs related to the pharmaceutical industry in the U.S. including Informed Medical Communications merged with IC Axon, Prime-Med Point of Care launched the website www.pri-medpointofcare.com, and PDI launched its EngageCE division.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics